Oral Sleep Apnea Devices Market Size & Growth Forecast 2026–2035, By Segments (Product, Sales Channel, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Oral Sleep Apnea Devices Market size was more than USD 955.24 Million in 2025 and is set to grow at a 6.9% CAGR between 2026 and 2035, surpassing USD 1.86 Billion by 2035. The industry revenue for 2026 is assessed at USD 1.01 billion.

• Base Year Value (2025): USD 955.24 Million
• CAGR (2026-2035): 6.9%
• Forecast Year Value (2035): USD 1.86 Billion
• Historical Data Period: 2022-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Oral Sleep Apnea Devices Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America leads due to established treatment pathways, stronger provider networks, and wider acceptance of customized oral appliance therapy.
  • Asia Pacific is projected to grow at a 7.8% CAGR, supported by improving diagnosis rates and expanding dental and sleep care access.

• Segment Momentum:

  • Mandibular Advancement Devices lead the market due to strong clinical familiarity, routine use in dental sleep medicine, and broad patient acceptance for managing mild to moderate obstructive sleep apnea and snoring.
  • Online Sales is the fastest-growing channel as consumers increasingly research sleep solutions independently and prefer convenient purchasing options with easier product access and transaction completion.

• Market Expansion Drivers:

  • Rising global obstructive sleep apnea prevalence increasing demand for non-invasive oral appliance therapies.
  • Growing transition from PAP devices to comfortable mandibular advancement appliances improving patient compliance.
  • Expanding telehealth-enabled sleep disorder diagnosis supporting direct-to-consumer oral appliance adoption.

• Leading Market Participants:

  Leading companies in the oral sleep apnea devices market include ResMed Inc. (United States), SomnoMed Limited (Australia), ProSomnus Sleep Technologies, Inc. (United States), Vivos Therapeutics, Inc. (United States), Koninklijke Philips N.V. (Netherlands), Oventus Medical Ltd. (Australia), Airway Management Inc. (United States), Whole You, Inc. (United States), Apnea Sciences Corporation (United States), DynaFlex (United States).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 955.24 Million
  • Projected Market Size: USD 1.86 Billion by 2035
  • Growth Forecasts: 6.9% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Mandibular Advancement Devices (Product) | Direct Sales (Sales Channel) | Homecare Settings (End-use)
  • Emerging Opportunity Segment: Tongue Retaining Devices (Product) | Online Sales (Sales Channel) | Homecare Settings (End-use)

Market Growth Drivers and Industry Trends

Rising global obstructive sleep apnea prevalence increasing demand for non-invasive oral appliance therapies

As obstructive sleep apnea is identified in a larger share of the adult population, treatment pathways are widening beyond traditional device-led intervention and increasing demand for the oral sleep apnea devices market. A growing diagnosed base means more patients presenting with mild to moderate disease, CPAP intolerance, or preference for less disruptive treatment, which makes oral appliance therapy a practical first-line or alternative option. This shifts prescribing behavior among sleep physicians and dentists toward mandibular advancement solutions that can be fitted, adjusted, and used without the infrastructure burdens associated with more complex therapies, contributing to market size growth through higher treatment conversion from diagnosis to actual device adoption.

Growing transition from PAP devices to comfortable mandibular advancement appliances improving patient compliance

Patient adherence is becoming a decisive factor in treatment selection, and that is supporting market development in the oral sleep apnea devices market as clinicians respond to real-world limitations of PAP use. Many patients discontinue or underuse PAP devices because of discomfort, noise, mask fit issues, or lifestyle disruption, while mandibular advancement appliances offer a lower-friction alternative that is easier to integrate into nightly routines. This practical compliance advantage influences physician recommendations, encourages dental sleep medicine referrals, and supports replacement demand from previously treated patients who remain inadequately managed on PAP, increasing market penetration through sustained long-term use rather than one-time device uptake.

Expanding telehealth-enabled sleep disorder diagnosis supporting direct-to-consumer oral appliance adoption

Remote screening, virtual consultations, and home-based diagnostic pathways are reshaping how patients enter care, reinforcing market demand for the oral sleep apnea devices market by reducing the friction between symptom recognition and treatment initiation. Telehealth models make it easier for patients to move from sleep assessment to appliance evaluation without navigating multiple in-person visits, which is particularly relevant for individuals seeking discreet, non-invasive treatment options. This is influencing market adoption through direct-to-consumer channels, digital patient acquisition strategies, and more streamlined coordination between sleep specialists and dental providers, allowing oral appliance companies to reach previously underserved or convenience-driven patient segments.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising global obstructive sleep apnea prevalence increasing demand for non-invasive oral appliance therapies	2.00%	Moderate	North America, Europe	High	Near Term
Growing transition from PAP devices to comfortable mandibular advancement appliances improving patient compliance	1.80%	Moderate	North America, Asia Pacific	High	Near Term
Expanding telehealth-enabled sleep disorder diagnosis supporting direct-to-consumer oral appliance adoption	1.30%	Low	Asia Pacific, North America	Emerging	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the largest regional market share in 2025 for the oral sleep apnea devices market, supported by established diagnosis and treatment pathways for sleep-disordered breathing and wider patient access to dental and sleep medicine services. The region’s leadership is aided by stronger clinical awareness of oral appliance therapy, a more developed network of qualified providers, and higher acceptance of customized devices in routine care. In practice, this means patients are more likely to be screened, referred, fitted, and monitored through coordinated care channels, which sustains steady device demand across the region.

Asia Pacific is projected to expand at a 7.8% CAGR over the forecast period, with growth in the oral sleep apnea devices market accelerating as diagnosis rates improve and access to treatment broadens across major healthcare systems. Adoption is being propelled by rising recognition of sleep apnea as an underdiagnosed condition and by the gradual expansion of dental and sleep care capabilities that make oral devices more available in clinical settings. As provider familiarity increases and treatment access becomes more practical for a larger patient base, the region is seeing stronger uptake patterns that support faster market expansion.

Regional Market Attractiveness & Strategic Fit Matrix
Parameter	North America	Asia Pacific	Europe	Latin America	MEA
Innovation Hub	Advanced	Developing	Advanced	Emerging	Nascent
Cost-Sensitive Region	Low	Medium	Low	High	High
Regulatory Environment	Supportive	Neutral	Restrictive	Neutral	Neutral
Demand Drivers	Strong	Strong	Strong	Moderate	Weak
Development Stage	Developed	Developing	Developed	Emerging	Emerging
Adoption Rate	High	High	High	Medium	Low
New Entrants / Startups	Dense	Moderate	Dense	Sparse	Sparse
Macro Indicators	Strong	Stable	Stable	Weak	Weak

Key Country Insights

United States

Customized Therapy Solutions

The U.S. oral sleep apnea devices market is driven by demand for customized mandibular advancement devices that provide comfortable alternatives to conventional therapies. Dental sleep medicine providers in the U.S. continue expanding digital workflows and patient-specific appliance manufacturing.

Japan

Compact Patient Comfort

Japan emphasizes compact, comfortable oral sleep apnea devices designed to improve treatment acceptance among patients. Dental professionals in Japan continue integrating digital impressions and precision manufacturing to deliver well-fitted appliances for obstructive sleep apnea management.

South Korea

Digital Appliance Manufacturing

South Korea is expanding the use of digital dentistry technologies for producing highly customized oral sleep apnea devices. Clinics across South Korea increasingly leverage CAD/CAM workflows to improve appliance fit, production efficiency, and patient comfort.

Germany

Clinical Dental Collaboration

Germany promotes close collaboration between dental specialists and sleep physicians to improve oral appliance therapy outcomes. Providers in Germany increasingly adopt digitally designed devices that enhance treatment precision while supporting long-term patient adherence.

France

Integrated Sleep Care

France supports oral sleep apnea devices through coordinated treatment pathways involving sleep clinics and dental practitioners. Healthcare providers in France continue encouraging personalized oral appliance therapy for suitable patients seeking non-invasive treatment options.

Italy

Specialist Dental Solutions

Italy focuses on expanding specialist dental services that deliver tailored oral sleep apnea devices for long-term therapy. Dental professionals in Italy increasingly prioritize precise appliance adjustment and patient follow-up to improve treatment effectiveness and compliance.

Segment Leadership and Growth Trends

  Product Segment Analysis: Mandibular Advancement Devices (Largest Segment) vs Tongue Retaining Devices (Fastest-Growing Segment)

Mandibular Advancement Devices held the largest share of the oral sleep apnea devices market in 2025, aided by their established role in managing mild to moderate obstructive sleep apnea and snoring. Their leadership is underpinned by broader clinical familiarity, routine use in dental sleep medicine, and stronger patient acceptance in cases where a forward-jaw positioning approach is considered practical and effective. This combination of established treatment use and provider confidence keeps Mandibular Advancement Devices at the center of product demand in the oral sleep apnea devices market.

Tongue Retaining Devices are emerging as the fastest-growing segment in the oral sleep apnea devices market as demand rises for alternatives suited to patients who may not tolerate mandibular repositioning. Their momentum is tied to practical fit considerations, particularly in cases where jaw advancement is less suitable or patient comfort needs differ from standard oral appliance use. As treatment selection becomes more individualized, Tongue Retaining Devices are seeing wider adoption relative to other product types by addressing a more specific but increasingly recognized patient requirement.

Sales Channel Segment Analysis: Direct Sales (Largest Segment) vs Online Sales (Fastest-Growing Segment)

Direct Sales accounted for the largest share of the oral sleep apnea devices market in 2025, reflecting the importance of clinically guided product selection and patient-specific fitting in this category. The channel remains dominant because oral sleep apnea devices often involve consultation with dentists, sleep specialists, or other providers who influence product choice and support treatment adoption. That structured purchasing pathway reinforces the leading share of Direct Sales across the oral sleep apnea devices market.

Online Sales represent the fastest-growing channel in the oral sleep apnea devices market, encouraged by rising consumer preference for more accessible and convenient purchasing options. Growth is gaining pace as patients increasingly research sleep-related solutions independently and look for easier product access outside traditional provider-led channels. Compared with direct purchasing routes, Online Sales benefit from lower friction in product discovery and transaction completion, which is helping the channel expand more quickly.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Product	Mandibular Advancement Devices, Tongue Retaining Devices, Others	Mandibular Advancement Devices	Tongue Retaining Devices
Sales Channel	Direct Sales, Distributors, Online Sales	Direct Sales	Online Sales
End-use	Hospitals, Homecare Settings, Sleep Clinics, Others	Homecare Settings	Homecare Settings

Competitive Landscape and Market Positioning

Major players in the oral sleep apnea devices market:

1. ResMed Inc. (United States)

2. SomnoMed Limited (Australia)

3. ProSomnus Sleep Technologies Inc. (United States)

4. Vivos Therapeutics Inc. (United States)

5. Koninklijke Philips N.V. (Netherlands)

6. Oventus Medical Ltd. (Australia)

7. Airway Management Inc. (United States)

8. Whole You Inc. (United States)

9. Apnea Sciences Corporation (United States)

10. DynaFlex (United States)

The oral sleep apnea devices market is evolving through increased demand for comfortable and non-invasive treatment solutions designed to improve patient compliance and long-term therapy outcomes. Manufacturers are focusing on ergonomic device customization, digital fitting technologies, and improved airway support mechanisms to enhance treatment effectiveness. Rising awareness regarding sleep disorders and preventive healthcare is also supporting growth within the oral sleep apnea devices market.

Competitive Dynamics and Strategic Insights
Assessment Parameter	Assigned Scale	Scale Justification
Market Concentration	Medium	Led by ResMed, Philips, and Vivos Therapeutics, but smaller players like SomnoMed compete.
M&A Activity / Consolidation Trend	Moderate	Strategic partnerships, e.g., ResMed’s 2023 Bittium deal, but limited large-scale mergers.
Degree of Product Differentiation	High	Customizable oral appliances (e.g., Vivos’ CARE devices) tailored for patient comfort.
Competitive Advantage Sustainability	Durable	Growing OSA prevalence and home care trends support sustained demand for oral devices.
Innovation Intensity	High	Advances in ergonomic designs and AI-driven monitoring enhance device efficacy.
Customer Loyalty / Stickiness	Moderate	Patient comfort drives loyalty, but high costs and alternatives like CPAP reduce stickiness.
Vertical Integration Level	Medium	Players control design and production, but distribution often relies on dental clinics.

Industry Development/News

Company Name	Date	Key Development
ResMed	May-25	ResMed acquired VirtuOx, a specialized independent diagnostic testing facility, to integrate home-based diagnostic services into its digital sleep-health ecosystem. This strategic move aims to streamline the patient care pathway by reducing bottlenecks between initial evaluation and the initiation of obstructive sleep apnea therapy.
Sleep Number	Mar-25	Sleep Number integrated its BreatheIQ app with the GEM SLEEP virtual care clinic. This partnership provides 53 million health-plan members with a streamlined digital pathway to connect with specialized clinicians for OSA diagnosis and treatment planning, bypassing traditional barriers to care.
Vivos Therapeutics	Oct-24	Vivos Therapeutics secured new CPT codes from the American Medical Association for its CARE oral medical devices. This regulatory milestone facilitates standardized insurance coverage and reimbursement for its airway remodeling technology, significantly improving market access for patients with obstructive sleep apnea.
Apnimed	Sep-24	Apnimed and Shionogi expanded their collaborative efforts within the Shionogi-Apnimed Sleep Science (SASS) joint venture. This partnership focuses on the development of novel pharmacological therapies as non-invasive alternatives to oral devices and CPAP, directly addressing the underlying neurobiological causes of upper airway collapse in OSA patients.
EnsoData	Feb-24	EnsoData received FDA clearance for its AI-powered diagnostic software that utilizes data from pulse oximeters to identify sleep-related breathing disorders. This technology enhances the scalability of at-home sleep apnea testing, providing a critical digital tool for rapid patient screening and diagnostic triage in sleep medicine.
Vivos Therapeutics	Nov-23	Vivos Therapeutics received FDA clearance for its CARE (complete airway repositioning and expansion) oral appliances for the treatment of obstructive sleep apnea. This regulatory approval provided the company with a significant expansion of its clinical product portfolio, enabling it to target a broader range of OSA patient demographics.